Holding(s) in Company

Summary by AI BETAClose X

JPMorgan Chase & Co. reported on 10-Nov-2026 that as of 06-Nov-2026 it held 5.005641% of Spire Healthcare's voting rights, comprising 75,799 direct shares (0.018820%) and 20,084,896 voting rights (4.986821%) via cash-settled equity swaps; total voting rights outstanding are 20,160,695. The position is down from a prior notification of 5.345999% (0.901099% direct, 4.444900% instruments), a reduction of 0.340358 percentage points. The swaps have expiries between 22/02/2027 and 08/05/2031, representing substantial derivative exposure that could affect market liquidity and perceived shareholder support.

Disclaimer*

UK 100

Latest directors dealings